According to reports from Globes Online, the Protalix Biotherapeutics (AMEX: PLX) CEO commented on recent rumors that Teva Pharmaceutical Industries ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE